Please use this identifier to cite or link to this item:
|Title:||Perinatal transmission of hepatitis B virus: an Australian experience||Authors:||Wiseman, Elke;Fraser, Melissa A;Holden, Sally ;Glass, Anne;Kidson, Bronwynne L;Heron, Leon G;Maley, Michael W;Ayres, Anna;Locarnini, Stephen A;Levy, Miriam T||Affliation:||Central Coast Local Health District||Issue Date:||4-May-2009||Source:||190(9):489-92||Journal title:||The Medical journal of Australia||Department:||Radiology||Abstract:||To determine the rate of perinatal hepatitis B virus (HBV) transmission in an Australian setting and to identify maternal virological factors associated with highest risk of transmission. A prospective, observational study of perinatal transmission of HBV. Participants were pregnant women attending Sydney South West Area Health Service antenatal clinics who tested positive for hepatitis B surface antigen (HBsAg), and their babies. All babies were routinely offered hepatitis B immunoglobulin (HBIG) and HBV vaccination. Babies positive for HBsAg at 9-month follow-up underwent further virological testing, including HBV DNA sequencing. The study was conducted between August 2002 and May 2008. HBV DNA levels and demographic characteristics of HBsAg-positive pregnant women; proportion of their infants with active HBV infection at 9-month follow-up; maternal characteristics affecting transmission rate; HBV DNA sequencing of infected infants and their mothers. Of 313 HBsAg-positive pregnant women, 213 (68%) were HBV DNA-positive and 92 (29%) were positive for hepatitis B "e" antigen (HBeAg); 138 babies born to HBV DNA-positive mothers were tested for HBV infection (HBsAg positivity) at about 9 months of age. Four cases of transmission were identified. All four mothers had very high HBV DNA levels (> 10(8) copies/mL) and were HBeAg-positive. Three of the four infants were infected with wild-type HBV strains, with identical maternal/infant isolates. The fourth mother-infant pair had an S gene variant, HBV D144E, which has been previously reported in association with vaccine/HBIG escape. (Unfortunately, HBIG was inadvertently omitted from the immunisation schedule of this infant.) Transmission rates were 4/138 (3%) from HBV DNA-positive mothers overall, 4/61 (7%) from HBeAg-positive mothers, and 4/47 (9%) from mothers with very high HBV DNA levels. No transmission was seen in 91 babies of mothers with HBV DNA levels < 10(8) copies/mL. In this cohort, HBV perinatal transmission was restricted to HBeAg-positive mothers with very high viral loads.||URI:||https://hdl.handle.net/1/2335||DOI:||10.5694/j.1326-5377.2009.tb02524.x||Pubmed:||https://pubmed.ncbi.nlm.nih.gov/19413519||ISSN:||0025-729X||Publicaton type:||Journal Article||Keywords:||Obstetrics
Newborn and Infant
|Appears in Collections:||Radiology|
Show full item record
checked on May 31, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.